
Olanzapine Combo Reduces Chemo-Induced Nausea, Vomiting in Breast Cancer
The addition of olanzapine (Zyprexa) at a dose of 5 mg to triplet antiemetic therapy, including a NK-1 receptor antagonist, palonosetron (Aloxi), and dexamethasone, exhibited significant overall antiemetic efficacy in patients with breast cancer previously …